Glenmark Pharmaceuticals

Glenmark Pharma Posted Revenue Growth of 12.4 % in FY 2021-22

Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company, today announced its financial results for the fourth quarter ended March 31, 2022.